Patenting Medical Use Inventions in China A medical use of a product may relate to i) the use of a new drug to treat a disease (“first medical use”); ii) the use of a known drug to treat a new
the Patent Law of the People's Republic of China(Decision)”. The amended rules, which will come into force on January 20, 2024, mainly cover the following aspects: improving the patent application
marketing license in China. According to the Transitional Measures, the PTE system applies to patents related to new drugs obtaining the marketing license since June 1, 2021. 1.3 Other common issues
On June 29, 2023, China’s State Administration for Market Regulation (SAMR) released the amended Provisions on Prohibiting the Abuse of Intellectual Property Rights to Exclude or Restrict
On April 22, the Supreme People's Court (SPC) released its report on the "Judicial Protection of Intellectual Property Rights by Chinese Courts (2023)". Data indicates that over the past year, courts ...
China had more than 4.015 million valid invention patents by the end of 2023 (excluding Hong Kong, Macao, and Taiwan), said Hu Wenhui, deputy director of the China National Intellectual Property
The total number of copyright registrations nationwide reached 8,923,901 in 2023, a year-on-year increase of 40.46%, according to news released by the National Copyright Administration of China (NCAC
BEIJING, March 22 (Reuters) - China's cyberspace regulator on Friday issued rules to facilitate and regulate cross-border data flow, clarifying reporting standards for security assessments of
, announced today that China Mobile Communications Group Co., Ltd. (China Mobile), the largest mobile network operator in the world, with more than 990 million subscriptions, has joined the OIN community. As
A recent report by the China National Intellectual Property Administration(CNIPA) reveals that China led the world in green and low-carbon patent applications in 2023, with a 20% year-on-year